Singapore’s national HealthTech agency, Synapxe, has launched a series of AI-driven initiatives and collaborations aimed at transforming the country’s public healthcare landscape. Announced during its inaugural AI Accelerate conference on 16 June, the agency introduced several strategic partnerships and prototype solutions, underscoring its efforts to build a robust, AI-enabled healthcare ecosystem.
The one-day event drew over 400 participants, including leaders from healthcare, technology, academia, and government. Health Minister Ong Ye Kung attended as guest-of-honour. Organised at the Punggol Digital District, Singapore’s first smart and sustainable district, the event served as a platform to promote AI talent development, highlight emerging applications, and accelerate digital transformation across the sector.
Strengthening AI infrastructure and partnerships
During the conference, Synapxe announced four new collaborations with global tech companies to boost healthcare innovation and safety. These partnerships aim to expand the capabilities of existing platforms such as HEALIX, Synapxe’s national cloud-based analytics system, and Tandem, its secure generative AI (GenAI) platform.
A key collaboration involves OpenAI, which will explore how its multi-agent framework can support daily healthcare tasks in Singapore. A prototype, developed using OpenAI’s Agents SDK, has already been created to assist with services like appointment booking and general healthcare enquiries. According to Synapxe, all conversations via the prototype are private and excluded from model training by default.
Synapxe also signed a memorandum of understanding (MOU) with AIDX TECH to focus on AI safety and reliability. The partnership will include testing AI models through AIDX’s platform, setting up joint labs, creating best practice frameworks, and delivering specialised training. The goal is to help healthcare institutions implement compliant and trustworthy AI tools.
Further strengthening its AI capabilities, Synapxe announced an MOU with Databricks. The collaboration will enhance HEALIX through co-developed predictive care use cases, a Data and AI Factory, and training programmes. Over the next three years, healthcare professionals in Singapore will receive Databricks certifications via the HEALIX Data and AI Academy.
Another MOU was signed with Google Cloud to improve HEALIX and Tandem using tools such as BigQuery, Vertex AI and the Agent2Agent Protocol. The agreement includes a training programme for over 300 data engineers, scientists and analysts across Singapore’s public healthcare institutions.
Building predictive and preventive tools
Alongside partnerships, Synapxe showcased new AI-driven tools aimed at strengthening early intervention and preventive care. A notable example is Synseh, a proof-of-concept using computer vision and AI to analyse tongue images, inspired by Traditional Chinese Medicine. The tool explores how visual wellness indicators could inform individual health assessments.
Addressing sarcopenia – the loss of muscle mass with age – Synapxe has partnered with the National Healthcare Group to trial ASPIRE, an AI-based assessment tool. Deployed across Tan Tock Seng Hospital and NHG Polyclinics, ASPIRE supports early detection and screening of the condition in community settings.
Two new AI imaging tools are also being implemented on AimSG, the national AI Medical Imaging Platform. A chest X-ray model for tuberculosis detection is set to be deployed at the National Tuberculosis Screening Centre under NHG. Separately, a bone trauma AI model is being used at Woodlands Health’s emergency department to improve fracture detection and treatment times.
To make health information more accessible, Synapxe is preparing to launch HealthHub AI later this year. The assistant, currently in beta, will offer multilingual, evidence-based health content via text and voice. More than 1,800 sessions have been recorded so far, with an average user rating of 4.5 out of 5.
Empowering healthcare professionals with GenAI skills
Beyond product development, Synapxe is investing in AI literacy among healthcare professionals. The GenAIus Challenge, launched in April 2024, connected over 160 participants with tech partners including AWS, Microsoft, Avanade, and Google Cloud. The initiative helped participants develop GenAI-based solutions across 70 use cases, eight of which were showcased at AI Accelerate.
One example is CareScribe, developed by Alexandra Hospital and Avanade. This multi-modal tool captures speech, images, and handwritten notes to improve nursing handovers. It stands out for its ability to recognise medical terminology, which enhances accuracy and reduces documentation time for nurses.
In a separate initiative, the AWS Large Language Model (LLM) League 2025 offered hands-on GenAI experience to participants regardless of technical background. Over five weeks, teams developed and fine-tuned LLMs, with the top four presenting their work at the conference for live audience voting.
Synapxe emphasised that all AI tools undergo rigorous validation to ensure patient safety and responsible use. “AI holds immense promise for transforming healthcare through innovation,” said Ngiam Siew Ying, CEO of Synapxe. “Together with our partners, we transform data into vision, ensuring that the human experience remains at the heart of healthcare.”
